Archive for July, 2011

Silencer S2200 Centrifuge by Global Focus Marketing & Distribution, Ltd.: Class I Recall – Biohazardous Materials May be Released

Potential for Centrifuge bucket and insert not being seated on the rotor, breaking the lid and being forced out of the centrifuge, which may result in serious personal injury and damage to the surrounding area.

Tags:

FDA Approves First Drug to Treat Urinary Incontinence in Female Dogs

Incurin is indicated for the control of estrogen-responsive urinary incontinence in ovariohysterectomized (spayed) female dogs.

Tags:

Methylene Blue: Drug Safety Communication – Serious CNS Reactions Possible When Given to Patients Taking Certain Psychiatric Medications

Symptoms may include mental changes (confusion, hyperactivity, memory problems), muscle twitching, excessive sweating, shivering or shaking, diarrhea, trouble with coordination and/or fever.

Tags:

Zyvox (linezolid): Drug Safety Communication – Serious CNS Reactions Possible When Given to Patients Taking Certain Psychiatric Medications

Symptoms may include mental changes (confusion, hyperactivity, memory problems), muscle twitching, excessive sweating, shivering or shaking, diarrhea, trouble with coordination and/or fever.

Tags:

July 28 Webinar: Home Use of Medical Devices

On July 28, FDA will host an online session about the agency’s plans to address the increased use of medical devices in the home.

Tags:

FDA issues draft guidance on device changes that warrant new premarket review

The U.S. Food and Drug Administration today issued draft guidance that clarifies when changes or modifications to a previously cleared 510(k) device require a new premarket submission.

Tags:

FDA’s MedWatch Safety Alerts: June 2011

FDA warns consumers about a wart and mole remover that can cause severe skin burns, an unapproved drug sold as a “sexual enhancer,” a diabetes medicine that carries an increased risk of bladder cancer, and more.

Tags:

Foodborne outbreak potentially associated with papaya distributed by Agromod Produce, Inc.

The FDA is taking steps to protect the public following the identification of Salmonella Agona in Agromod Produce, Inc.’s supply of fresh papayas. The FDA is advising consumers not to eat papayas from Agromod Produce, Inc. The company is voluntarily recalling the product. The papayas were imported from Mexico, and may be linked to the reported cases of Salmonella Agona. Recent sampling by the FDA found the outbreak strain in two papaya samples: one collected at the Agromod Produce, Inc. location in McAllen, Texas, and one collected at the U.S. border destined for Agromod Produce, Inc. The shipments that tested positive with the outbreak strain were not distributed in the U.S.

Tags:

FDA Center for Drug Evaluation and Research develops strategic science and research agenda

A U.S. Food and Drug Administration report from its Center for Drug Evaluation and Research (CDER), available today in the Federal Register, identifies the current regulatory science needs that will guide CDER’s strategic planning of internal research initiatives and contributions to the development of agency regulatory science efforts.

Tags:

Agromod Produce, Inc. Recalls Papaya Because Of Possible Health Risk

Agromod Produce, Inc. of McAllen, Texas is recalling all Papayas, because they have the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain.

Tags: